Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies”

3 trials

Showing 3 of 3 results

Post-approval studies (Phase 4)Study completedNCT02359526
What this trial is testing

A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients

Who this might be right for
Diabetic Macular Edema
Association for Innovation and Biomedical Research on Light and Image 12
Post-approval studies (Phase 4)Study completedNCT02472366
What this trial is testing

A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy

Who this might be right for
Chronic Diabetic Macular Edema
Alimera Sciences 16
Not applicableUnknownNCT01998412
What this trial is testing

Iluvien Registry Safety Study

Who this might be right for
Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies
Alimera Sciences 559

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation